Resources from the same session
Early clinical strategies and Project Optimus considerations for novel-novel drug combinations
Presenter: Timothy Anthony Yap
Session: Novel combinations in molecular oncology: Bench to bedside to the regulator
Resources:
Slides
Webcast
Regulatory perspectives and considerations for novel combination drug approval
Presenter: Sinan Sarac
Session: Novel combinations in molecular oncology: Bench to bedside to the regulator
Resources:
Slides
Webcast